What is the current stock price of BiomX Inc. (PHGE)?

As of the latest market data, BiomX Inc. (PHGE) is trading at $1.55. The stock has seen a loss of -4.32% today.

Does BiomX Inc. (PHGE) pay a dividend?

Based on current data, BiomX Inc. does not have a confirmed active dividend policy.

What is the market cap of BiomX Inc.?

The current market capitalization of BiomX Inc. (PHGE) is approximately unavailable.

PHGE

BiomX Inc.·Healthcare

1.55

4.321%(−0.07)

Close Price

1.51

2.581%(−0.04)

After Hours

Last Updated: — ET

52W L: $0.3652W H: $14.71

PHGE NEWS

globenewswire.com

14h ago

BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations

Roy brings defense leadership, digital infrastructure, and large scale commercialization experience as BiomX advances its defense and security transition Roy brings defense leadership, digital infrastructure, and large scale commercialization experience as BiomX advances its defense and security transition

globenewswire.com

May 6

BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response

globenewswire.com

Apr 16

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

AI-driven command and control platform applied in real-world railway operations, supporting broader infrastructure and security use cases AI-driven command and control platform applied in real-world railway operations, supporting broader infrastructure and security use cases

globenewswire.com

Apr 13

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Acquisition expands BiomX's defense portfolio with aligned capabilities designed to integrate across detection, analysis, and response, reinforcing its position in AI-enabled security systems Acquisition expands BiomX's defense portfolio with aligned capabilities designed to integrate across detection, analysis, and response, reinforcing its position in AI-enabled security systems

seekingalpha.com

Apr 10

BiomX Inc. (PHGE) Shareholder/Analyst Call Prepared Remarks Transcript

globenewswire.com

Apr 10

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments

Company Profile

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease; and BX003, an orally administered phage cocktail, which is in Phase 1b/2a that targets a bacterial target present in the gut of IBD and PSC patients. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2019-03-13

Beta

1.03

Websitewww.biomx.com↗